News | November 18, 2024
Richard Manning provided trial testimony that contributed to a decisive legal victory for biotech startup Inhibrx in a $460 million trade secrets case brought by I-Mab Biopharma in Delaware federal district court.
Regulators and courts regularly rely on economic insights to determine the competitive impact of specific transactions and conduct. In this legal environment, Secretariat has earned a position as a preeminent resource for trusted, independent antitrust and competition analysis that is backed by experience with key economic issues, state-of-the-art empirical analysis, and an ability to present complex information in clear, understandable terms.
Antitrust investigations and litigation of proposed mergers and acquisitions (M&A) or allegedly anticompetitive conduct — whether government-initiated or a private action — requires the kind of clear, expert economic analysis Secretariat’s antitrust economists are known for and have provided for decades. Across nearly all industries, our experts have been there – retained in more than 1,400 antitrust matters with a collective deal value above $500 billion.
Antitrust review of M&A transactions by regulators inherently and routinely involves answering economic questions. How is a market defined? What will be the transaction’s competitive effects? Answering these and related questions requires a thorough grasp of the nature of competition in specific markets and detailed empirical analysis and modeling of market conditions. Obtaining clearance for the transaction depends on clear analysis and persuasive presentation to regulators. Secretariat’s experts provide the kind of thorough data analysis, modeling, and objective advice clients need when considering a transaction, as well as the detailed and fact-based documentation and presentations regulators value.
When antitrust disputes emerge, there is no substitute for experts with the ability to present clear and understandable economic analyses to judges, juries, and arbitrators. Secretariat’s experts provide straightforward and convincing testimony in disputes involving price fixing, bid rigging, and monopolization claims. Whether the testimony relates to class certification, damage estimation, or theories of competitive harm, our experts are adept at merging sound economic evaluations and reasoning with prevailing legal standards, actual case law, and the unique facts of every matter.
Dr. Sun specializes in economic analysis for antitrust and intellectual property matters. His experience includes economic analysis in merger review, price fixing, and abuse of dominance cases on antitrust issues, and economic analyses and damage calculations in patent, copyright, trademark, and trade secret cases.
Richard Manning provided trial testimony that contributed to a decisive legal victory for biotech startup Inhibrx in a $460 million trade secrets case brought by I-Mab Biopharma in Delaware federal district court.
Under Dr. Guyer’s leadership, the new Engineering & Scientific Consulting practice will provide the critical research, analysis, and investigations expertise necessary to solve the challenging science, engineering, and regulatory questions behind why products fail and the implications for stakeholders.
The US Music Industries: Jobs & Benefits — 2024 Report
Robert Stoner and Jéssica Dutra have recently published The U.S. Music Industries: Jobs & Benefits—2024 Report for the Recording Industry Association of America where we measure the music industries’ economic impact nationwide, which overall contribute $212 billion to the GDP and account for 2.5 million jobs.